Assessment of Changes in Hormonal Levels in Women with Menstrual Dysfunction Who Suffer from COVID-19
Abstract
According to the World Health Organization, the COVID-19 pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 620 million infections and
6.5 million deaths worldwide as of September 2022 [1]. Over the past few years, the COVID-19
pandemic has had a significant impact on the health and lives of people around the world. Numerous
retrospective studies have shown that age is a critical factor affecting the prognosis of patients with
COVID-19 (Guan et al., 2020). Additionally, gender is believed to play an important role in the
progression of COVID-19, as female patients have a better prognosis (Chen et al., 2020). Similarly,
some infectious diseases, such as MERS and SARS, have mild clinical symptoms and better outcomes
in women of childbearing age (Alghamdi et al., 2014; Karlberg et al., 2004). Researchers have been
studying COVID-19 since day one, and there is already robust data on the effects of infection with
the SARS-CoV-2 virus on the respiratory [2], circulatory [3] and nervous systems [4]. However, little
is known about the impact of COVID-19 on the reproductive system, especially the female
reproductive system. The impact of the COVID-19 pandemic on the female reproductive system and
changes in the menstrual cycle have been widely reported anecdotally and in the media [5].
References
Lovato A., De Filippis C. Clinical presentation of COVID-19: A systematic review focusing on upper airway symptoms. Ear Nose Throat J. 2020;99:569–576. doi: 10.1177/0145561320920762. [PubMed] [CrossRef] [Google Scholar]
Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583–590. doi: 10.1038/s41591-022-01689-3. [PMC free article] [
[PubMed] [CrossRef] [Google Scholar] Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267–269. doi: 10.1126/science.abm2052. [PubMed] [CrossRef] [Google Scholar]
Morgan E. Pandemic Periods: Why Women’s Menstrual Cycles Have Gone Haywire. [(accessed on 21 February 2022)]. Available online: https://www.theguardian.com/society/2021/mar/25/pandemic-periods-why-womens-menstrual-cycles-have-gone-haywire
Munro MG, Critchley HOD, Fraser IS. Corrigendum to “The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions” [Int J Gynecol Obstet 143(2018) 393–408]. Int J Gynaecol Obstet 2019; 144(2): 237 ( таблица)
Morgan E.P. Periods: why women’s menstrual cycles have gone haywire. Guardian. 2021; 25
Wang H., Mao Y., Ju L. et al. Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. Clin Chem. 2004;50(7):1237–1240. DOI: 10.1373/ clinchem.2004.031237.
Milla M., Harcourt B.H., Hickman C.J. et al. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res. 2005;107(1):93–101. DOI: 16/j.virusres.2004.09.004.
Guan W., Ni Z., Hu Y. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. DOI: 10.1056/NEJMoa2002032
American Association of Blood Banks. Update: impact of 2019 novel coronavirus and blood safety. (Electronic resource.) URL: http://www.aabb.org/advocacy/ regulatorygovernment/Documents/Impact-of-2019-Novel-Coronavirus-on-Blood-Donation.pdf. (access date: 16.08.2021).
European Centre for Disease Prevention and Control. Rapid Risk Assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus,
Wuhan, China; first update — 22 January 2020. ECDC: Stockholm; 2020.
CDC. Coronavirus Disease 2019 (COVID-19). 2020. (Electronic resource.) URL: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical- criteria.html (access date: 16.08.2021).
Devaux C.A., Rolain J.M., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020;55(5):105938. DOI: 2020.10593810.1016/j.ijantimicag..
AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001;276:39721-39726.
Acosta TJ, Ozawa T, Kobayashi S, Hayashi K, Ohtani M, Kraetzl WD, Sato K, Schams D, Miyamoto A. Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo. Biol Reprod 2000;63:1253-1261.
Ahmed A, Li XF, Shams M, Gregory J, Rollason T, Barnes NM, Newton JR. Localization of the angiotensin II and its receptor subtype expression in human endometrium and identification of a novel high-affinity angiotensin II binding site. J Clin Invest 1995;96:848-857.
Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C et al. The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology 2009;150:4316-4325.